BioMed Labs Iron microneedle patch — crescent-shaped transdermal delivery platform
Product

BioMed Labs Iron

A Ferrous Lactate microcrystal transdermal patch platform. Precision-engineered dissolvable microneedle technology — bypassing the GI tract entirely.

Active IngredientFerrous Lactate
Chemical ClassIron (II) Salt
Molecular FormulaC₆H₁₀FeO₆
Delivery FormMicrocrystal Matrix
Patch ArchitectureDissolvable Microneedle
Supply ChannelB2B Only
Active Ingredient

Ferrous Lactate — the precision iron salt.

Ferrous Lactate (Iron II Lactate) is selected as the active ingredient in BioMed Labs Iron for its biocompatibility profile and its suitability for microcrystal matrix formation. As an iron (II) salt of lactic acid, it offers a well-characterised chemical structure that supports consistent formulation within the dissolvable patch platform.

The microcrystal architecture is engineered to maintain consistent crystal morphology across production batches — a critical requirement for pharmaceutical-grade B2B supply.

Molecular FormulaC₆H₁₀FeO₆Iron (II) Lactate · MW 233.99 g/mol
Ferrous Lactate molecular structure — iron II salt pharmaceutical compound
FERROUS LACTATE · C₆H₁₀FeO₆
BioMed Labs Iron patch worn on wrist — close-up of transdermal microcrystal delivery
Microscopic view of BioMed Labs Iron microcrystal matrix structure
MICROCRYSTAL MATRIX · SEM
Patch Design

Crescent form. Microneedle precision.

BioMed Labs Iron is delivered via a crescent-shaped dissolvable microneedle patch. The crescent geometry is designed for ergonomic application and consistent skin contact across the full patch surface.

The microneedle array penetrates the stratum corneum on application, establishing a transdermal pathway for the Ferrous Lactate microcrystal matrix. Upon contact with interstitial fluid, the dissolvable substrate releases the active ingredient from the microcrystal structure.

ShapeCrescent
ArrayMicroneedle
SubstrateDissolvable
ContactTransdermal
Platform Attributes

Engineered for pharmaceutical supply.

Ferrous Lactate Formulation

Ferrous Lactate is selected for its biocompatibility profile and its suitability for microcrystal matrix formation within the dissolvable patch substrate.

Microcrystal Matrix Architecture

The active ingredient is structured into a precision microcrystal matrix — engineered for consistent crystal morphology and controlled dissolution characteristics.

Dissolvable Microneedle Platform

The patch substrate uses a dissolvable microneedle array that penetrates the stratum corneum, establishing a transdermal pathway for the Ferrous Lactate microcrystals.

Pharmaceutical-Grade Manufacturing

BioMed Labs Iron is formulated under pharmaceutical-grade manufacturing conditions, designed to meet the quality and consistency requirements of B2B supply chain partners.

Product Specifications

Technical overview.

Formulation
ActiveFerrous Lactate
FormMicrocrystal Matrix
SubstrateDissolvable Polymer
Patch Design
ArchitectureMicroneedle Array
ShapeCrescent (Custom)
ApplicationTransdermal
Supply
ChannelB2B Only
Minimum OrderOn enquiry
PackagingPharmaceutical-grade

Specifications are provided for informational purposes only. Full technical documentation is available to registered B2B partners upon enquiry. BioMed Labs Iron is intended for pharmaceutical supply and research applications only.

Ready to order BioMed Labs Iron?

60 microcrystal microneedle patches per box. $129. Free shipping. Order online today.